top of page

Webinar March 15th: Radiation Therapy in 2022: Rethinking the Target & the Case for Less Fractions

JG

Please join Chirag Shah, M.D. (Cleveland Clinic) and David Beyer, M.D. (Cancer Centers of Northern Arizona) for a discussion of how clinical and economic forces in 2022 are impacting treatment for breast cancer patients.

Please Register in Advance


 
 
 

Comments


  • LinkedIn
  • Twitter
  • YouTube

VeraForm is 510(k) cleared (IYE indication) by the FDA as a surgical implant to accurately visualize and constitute the reference frame for stereotactic radiosurgery and radiotherapy target localization.  In addition, the markers are indicated in situations where tissue needs to be marked for future medical procedures such as IMRT/IGRT

V2 No background_edited.png

© 2019,2020,2021,2022,2023, 2024 VIDERA SURGICAL INC.

bottom of page